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Jameson et al., 1995).94807 Villejuif
Thymic bone marrow (BM)-derived dendritic cellsFrance
(DCs) and macrophages (mw) are the main cell types²UniteÂ de Biologie du DeÂ veloppement
involved in negative selection that eliminates T cellsCentre National de la Recherche Scientifique
bearing self-reactive receptors in the medulla (KapplerURA1960 Institut Pasteur
et al., 1987; Sprent et al., 1988; Nossal, 1994). This pro-25 rue du Dr Roux
cess is also mediated by interactions of the TCR with75015 Paris
MHC±peptide. Thymic medullary epithelium (mTE) canFrance
also drive negative selection of autoreactive T cells.³ Institut National de la SanteÂ
Contact of immature thymocytes with MHC class I anti-et de la Recherche MeÂ dicale U 25
gens on mTE induces deletion of high avidity CD8 THoÃ pital Necker
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al., 1992; Hoffmann et al., 1992, 1995; Kosaka andFrance
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Studies on tolerance induction of CD4 T cells by mTEet de la Recherche MeÂ dicale U 391
have given conflicting results. In bone marrow chimera2 Avenue du Prof. Leon Bernard Rennes
(BMC) and thymus grafting experiments, a transient an-France
ergy of CD4 T cells has been reported that disappeared
when the cells leave the thymus (Gao et al., 1990; Webb
and Sprent, 1990; Sprent et al., 1993). However, in theseSummary
models, expression of foreign antigen may not be re-
stricted to thymic epithelium and could extend to BM-Thymic epithelium is involved in negative selection, but
derived thymic cells. Indeed, dGuo-treated E14 thymiits precise role in selecting the CD4 T cell repertoire
used for grafting contained residual mw and DCs (Jen-remains elusive. By using two transgenic mice, we
kinson et al., 1992). In BMC prepared with supralethalhave investigated how medullary thymic epithelium
irradiation, the presence of a minute population of resid-(mTE) and bone marrow (BM)-derived cells contribute
ual cells of BM origin could not be excluded. Toleranceto tolerance of CD4 T cells to nuclear b-galactosidase
induction by mTE free of BM-derived cells has been(b-gal). CD4 T cells were not tolerant when b-gal was
shown by Burkly et al. (1993). They used transgenic miceexpressed in thymic BM-derivedcells. In contrast, CD4
expressing I-E in mTE to show a partial deletion of Vb5
T cells of mice expressing b-gal in mTE were tolerized.
and Vb11 CD4 T cells reactive to a superantigen pre-
Tolerance resulted from presentation of endogenous
sented by I-E. A similar model was obtained by grafting
b-gal by mTE cells but not from cross-priming. mTE
of I-E1 E10 branchial clefts, which are free of hematopoi-
cells presented nuclear b-gal to a Th clone in vitro, etic cells. However, in contrast with the I-E transgenic
while thymic dendritic cells did not. The data indicate
mice, Vb5 and Vb11 CD4 T cells were not tolerized (Sa-
that mTE but not thymic BM-derived cells can use a
lauÈ n et al., 1992).MHC class II endogenous presentation pathway to
Tolerance induction by thymic epithelium has been
induce tolerance to nuclear proteins. studied with allogeneic MHC as foreign antigens or with
superantigens presented by allogeneic MHC. Allogeneic
Introduction MHC presents a large number of different peptides,
some of them cell specific (Bonomo and Matzinger,
T lymphocytes in the periphery express a T cell antigen 1993). Tolerance assay was based on the capacity of T
receptor (TCR) that recognizes peptides presented by cells to mount a proliferative response to allogeneic
the major histocompatibility complex (MHC). The reper- MHC expressed by professional antigen-presenting
toire of TCR specificities is subject to stringent selection cells (APCs). Therefore, T cell responsiveness could be
in the thymus to reduce waste, induce tolerance to self, obtained even if tolerance induction by thymic epithe-
and ensure protection. Positive selection allows imma- lium occurs. In this case, the response would concern
ture T cells expressing a TCR with a MHC-restricted peptides specifically presented by professional APCs
specificity to differentiate further. This mainly occurs but not by mTE.
To overcome these problems, we have tested the ca-
pacity of mTE to tolerize CD4 T cells to an intracellular‖ On leave of absence from Institut National de la SanteÂ et de la
Recherche MeÂ dicale U 396. protein, using transgenic animals in which expression
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of the antigen (b-gal) is restricted to the nucleus of mTE b-gal (data not shown). In both DC and mw, b-gal was
targeted to the nucleus. Double staining of Vim1 thymuscells. We have previously reported that these mice are
tolerant to class I±restricted b-gal epitopes and that this with X-gal and anticytokeratin MAb showed that epithe-
lial cells do not express b-gal (data not shown). Takentolerance concerns both high and low avidity CD8 T
cells (Oukka et al., 1996). Here, we report that mTE together, these results show that a subpopulation of
DCs and mw expresses nuclear b-gal in Vim1 thymus.induces tolerance to class II±restricted b-gal epitopes.
Responsiveness was restored in vitro when rIL-2 was
provided. In contrast, transgenic mice expressing b-gal b-Gal-Specific Proliferative Response
in the nucleus of DCs and mw were tolerant to class I± of LN Cells of Tg±b-Gal and Vim1 Mice
but not class II±restricted epitopes. In vitro presentation We took advantage of the pattern of b-gal expression
experiments showed that mTE cell lines (mTECs) pre- in Tg±b-gal and Vim1 thymus to compare the tolerogenic
sent MHC class II epitopes of nuclear b-gal, while freshly potential of mTE and BM-derived thymic cells for an
isolated thymic DCs and mw do not. The data indicate intracellular antigen.
that mTE but not thymic BM-derived cells can use a Tg±b-gal and Vim1 mice were subcutaneously primed
MHC class II endogenous presentation pathway to in- with b-gal in complete Freund's adjuvent (CFA) and cells
duce tolerance to nuclear proteins. from LN draining of the site of immunization were stimu-
lated in vitro with various doses of soluble b-gal. Figure
2 shows that Tg±b-gal and Vim1 mice did not exhibit
Results the same state of tolerance to class II b-gal epitopes.
LN cells from Tg±b-gal mice (30 of 30) did not mount a
b-Gal Expression in the Thymus significant proliferative response even when high doses
of Tg±b-Gal and Vim1 Mice of b-gal were exogenously provided. Surprisingly, unlike
Transgenic (Tg)±b-gal mice contained the b2nZ con- Tg±b-gal mice, all the Vim1 mice (11 of 11) responded
struct composed of the nuclear b-gal encoding nls±lacZ to b-gal. There was no difference in the strength of
gene under the control of the 59 regulatory sequence response between b-gal homozygous and b-gal hetero-
of the b2-microglobulin (b2m) (Cohen-Tannoudji et al., zygous Vim1 mice (data not shown). These results show
1992). Surprisingly, the pattern of expression of the lacZ that Tg±b-gal mice are tolerant to b-gal class II epitopes,
gene was not correlated to that of the endogenous b2m, while Vim1 mice are not.
and b-gal was detected in the thymus, central nervous
system,and skinbutnot inother organs including spleen
Tolerance of Tg±b-Gal Mice Is Induced by mTEand peripheral lymph nodes (LN). This may be due to
b-gal expression in Tg±b-gal mice was not limited tothe control of lacZ expression by regulatory elements
mTE but was also observed in nonlymphoid peripheralpresent in the integration site. X-gal staining of Tg±b-
tissues (skin and central nervous system). Therefore,gal thymus revealed the presence of very few b-gal1
tolerance to b-gal could result from a mechanism initi-cells that were localized in the medulla (Figure 1B).
ated by mTE, by b-gal expressing peripheral tissues, orb-gal1 cells were not found in the thymus of non-Tg
by both. To define the role of mTE in tolerance inductionlittermates (NTg±b-gal) (Figure 1A). The pattern of ex-
to b-gal, B6 nude mice were grafted with thymus frompression and intracellular distribution of b-gal in Tg±b-
neonate Tg±b-gal or NTg±b-gal mice. The b-gal-specificgal have been described previously (Oukka et al., 1996).
proliferative response was analyzed 3 months after thy-Double staining of Tg±b-gal thymus with antibodies to
mus grafting. At this time, thymus-grafted nude miceb-gal and cytokeratin showed that all b-gal1 cells were
had a normal amount of CD4 T cells in their LN. Nudeof epithelial origin. However, the majority of epithelial
mice grafted with NTg±b-gal thymus strongly respondedcells did not express b-gal. In addition, b-gal was exclu-
to b-gal, while nude mice grafted with Tg±b-gal thymussively detected in the nucleus of mTE cells.
did not (Figure 3). Both mice responded equally wellVim1 mice were produced by replacement of the vi-
to purified protein derivative. Since b-gal expression inmentin gene by the nls±lacZ gene (Colucci-Guyon et al.,
nude mice grafted with Tg±b-gal thymus was restricted1994). They express b-gal in several tissues including
to mTE, the data demonstrate that mTE induces toler-thymus. X-gal staining of the Vim1 thymus revealed the
ance of the CD4 T cell repertoire via a one-step mecha-presence of b-gal1 cells in the medulla and, to a lower
nism not requiring subsequent contact of CD4 T cellsextent, in the cortex (Figure 1C). Vim1 thymus contained
with b-gal-presenting peripheral cells.at least 100-fold more b-gal1 cells than Tg±b-gal thy-
mus. Since thymic DCs and mw express vimentin (Boyd
et al., 1993) itwas expected that these cells also express mTE-Induced Tolerance Is Reversible by rIL-2
Central tolerance following negative selection resultsb-gal. This was confirmed by a double staining of Vim1
thymus with X-gal and Iab-specific M5114, mw-specific from clonal deletion or anergy. Several studies have
suggested that both mechanisms can be involved inMac-1 or DC-specific N418 monoclonal antibodies
(MAbs). The large majority of b-gal1 cells were stained mTE-induced tolerance (Burkly et al., 1993; Sprent et
al., 1993). Therefore, tolerance of Tg±b-gal mice couldby M5114 MAb (Figures 1D and 1G). b-gal1 cells were
also stained by Mac-1 (Figures 1E and 1H) or N418 be explained by the deletion of the b-gal-specific T
helper (Th) repertoire or by its inactivation. T cell nonre-(Figures 1F and 1I) MAbs. However, b-gal1 cells corre-
sponded to a subset of thymic mw and DCs because activity due to anergy can be reversed in vitro when
rIL-2 is exogenously provided. LN cells from b-gal-the majority of Mac-11 and N4181 cells did not express
b-gal. About 10% of purified thymic DCs expressed primed Tg±b-gal and NTg±b-gal mice were stimulated
Tolerance Induction by Medullary Thymic Epithelium
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Figure 1. b-Gal Expression in the Thymus of Tg±b-Gal and Vim1 Mice
(A) X-gal staining of NTg±b-gal thymus.
(B) X-gal staining of Tg±b-gal thymus.
(C) X-gal staining of Vim1 thymus.
(D, G) Double staining of Vim1 thymus with M5-114 and X-gal is shown at 2003 original magnification (D) and at 6003 original magnifica-
tion (G).
(E, H) Double staining of Vim1 thymus with Mac1 and X-gal at 1003 original magnification (E) and at 4003 original magnification (H).
(F, I) Double staining of Vim1 thymus with N418 and X-gal at 2003 original magnification (F) and at 4003 original magnification (I).
in vitro in the presence of exogenous b-gal and rIL-2 The anti-b-gal CTL reactivity of Vim1 mice (Figure 5C)
was compared with that of Tg±b-gal mice that are known(20 IU/ml). Figure 4 shows that rIL-2 restored the anti-
b-gal proliferative response of Tg±b-gal LN cells, sug- to be fully tolerant to class I b-gal epitopes (Figure 5B)
(Oukka et al., 1996). Like Tg±b-gal mice, Vim1 mice weregesting that anergy could be a mechanism of mTE-in-
duced CD4 cell tolerance in these mice. However, we tolerant to b-gal while they responded normally to
vaccinia virus (VV) (Figures 5E and 5F). This indicatescan not exclude the possibility that mTE induces toler-
ance by deleting high avidity Th cells, and that the re- that the subset of BM-derived thymic cells expressing
b-gal in Vim1 mice can deliver the signals necessary formaining low avidity Th cells require exogenous rIL-2 to
respond to b-gal. tolerance induction.
Tg±b-Gal and Vim1 Mice Are Tolerant
to Class I Epitopes of b-Gal MHC Class II Presentation of Nuclear b-Gal
by mTECsTaken together, the results suggest that mTE cells toler-
ize the CD4 T cell repertoire to nuclear proteins, while Tolerance in Tg±b-gal mice suggests that peptides from
nuclear b-gal are presented by MHC class II on theBM-derived thymic DCs and mw do not. Tolerance to
b-gal epitopes presented by MHC class I was tested surface of mTE. To test this hypothesis, the b-gal-spe-
cific TBG3 Th clone was stimulated with mTECs ex-by infecting mice with VVhrZ, which generates b-gal-
specific and vaccinia virus±specific cytotoxic T lympho- pressing b-gal in the nucleus. b-gal-expressing mTECs
were obtained by transfection with a lacZ-containingcytes (CTL) in nontransgenic mice (Figures 5A and 5D).
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Figure 3. Tolerance of Tg±b-Gal Mice Is Induced by mTE
Figure 2. b-Gal-Specific Proliferative Response of LN Cells from
LN cells from B6 nude mice grafted with NTg±b-gal thymus (openTg±b-Gal and Vim1 Mice
circles) or with Tg±b-gal thymus (closed circles) and immunized with
LN cells from NTg±b-gal (squares), Vim1 (open circles), and Tg±b-
b-gal in the hind footpad were stimulated in vitro with various doses
gal (closed circles) mice primed with b-gal in the hind footpad were of antigen. Control proliferative response to purified protein deriva-
in vitro stimulated with various doses of b-gal. Control proliferative tive was 43967 6 1200 and 34473 6 1010 (Tg±b-gal thymus grafted
response to purified protein derivative was 96992 6 1850 (NTg±b- nude mice), 54977 6 2423 and 45350 6 1267 (NTg±b-gal grafted
gal), 95949 6 1250 (Tg±b-gal), 78547 6 2323 cpm (Vim1). Prolifera- nude mice).
tionwas evaluated by radioactivity incorporation and was expressed
as mean of cpm.
supernatant of mTECX.10. In addition, b-gal could not
vector (mTEC2.3BG) or were derived from the Tg±b- be detected in thesupernatant of mTECX.10 by enzyme-
gal thymus (mTECX.10). Presentation experiments were linked immunosorbent assay or galactolight chemilumi-
also performed with mTECs infected with recombinant nescence (data not shown). This latter method detects
adenoviruses to induce b-gal expression in the nucleus
or in the cytosol. Intracellular distribution of b-gal is
shown in Figure 6. b-gal was exclusively localized in the
nucleusof mTECX.10 (Figure 6C), mTEC2.3 infected with
AdCMVnLacZ (Figure 6A), and mTEC2.3BG (data not
shown). b-gal was targeted to the cytosol of mTEC2.3
infected with AdCMVcLacZ lacking the nls sequence
(Figure 6B).
Figure 7A shows that presentation of exogenously
provided b-gal by mTEC2.3 is dose dependent. Presen-
tation of endogenous b-gal is shown in Figure 7B, where
mTEC2.3BGand mTECX.10 stimulate theTBG3 Th clone
without addition of exogenous b-gal. Presentation of
endogenous b-gal was confirmed using mTEC2.3 in-
fected with various doses of adenoviruses. Figure 7C
shows that both cytosolic and nuclear b-gal are pre-
sented by MHC class II complexes of mTEC2.3. The
intensity of proliferation of the TBG3 clone was depen-
dent on the level of infection.
To rule out the possibility that presentation resulted
from the uptake of b-gal released in the medium, LB27.4
cells were incubated with supernatant of mTEC2.3 in-
fected with AdCMVnLacZ (1,000 moi for 48 hr) (Figure
7D). LB27.4 cells were choosen because of their very
high efficiency in presenting exogenous b-gal (100 ng/ Figure 4. mTE-Induced Tolerance Is Reversible by rIL-2
ml of exogenous b-gal were sufficient to induce prolifer-
LN cells from NTg±b-gal (open symbols) mice, and Tg±b-gal (closed
ation of TBG3). Supernatant of infected mTEC2.3 did symbols) mice primed with b-gal in the hind footpad were in vitro
not contain enough b-gal to allow exogenous presenta- stimulated with various doses of b-gal in the presence (squares) or
absence (circles) of 20 IU of rIL-2.tion by LB27.4 cells. Similar results were obtained with
Tolerance Induction by Medullary Thymic Epithelium
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Figure 5. Tg±b-Gal and Vim1 Mice Are Tolerant to MHC Class I Epitope of b-Gal
Spleen cells from VVhrZ-infected NTg±b-gal (A, D), Tg±b-gal (B, E), Vim1 (C, F) mice were in vitro stimulated either with EL4.T20 cells (A, B,
C) or with VV-infected B6 spleen cells (D, E, F). Cytotoxicity was tested against EL4 cells (circles), VV-infected EL4 cells (triangles), and EL4.T20
cells (squares).
as low as 2 fg/ml of b-gal, while exogenous presentation The data showed that Tg±b-gal but not Vim1 mice
were tolerant to b-gal. Involvement of BM-derived cellsby mTECs requires more than 1 mg/ml of b-gal to be
significant. The data show that mTECs present cytosolic in tolerance induction in Tg±b-gal mice was ruled out,
as we have previously shown by BM grafting experi-and nuclear b-gal via the MHC class II endogenous pre-
sentation pathway. ments that BM-derived cells are completly devoid of
b-gal (Oukka et al., 1996). Cross-priming has beenThe absence of CD4 T cell tolerance in Vim1 mice
suggests that, unlike mTECs, thymic DC and mw can not suggested for tolerance induction to minor histocompat-
ibility antigens (von Boehmer and Hafen, 1986). Such ause the MHC class II endogenous pathway to present
nuclear b-gal. To test this hypothesis, TBG3 Th clone mechanism in our model would imply that thymic
BM-derived cells present b-gal locally released bywas stimulated in vitro with freshly isolated thymic DCs
from B6 and Vim1 mice. Figure 7E shows that thymic b-gal-expressing cells. This phenomenon is more likely
to occur in Vim1 mice, which have a higher number ofDCs of Vim1 mice only stimulated the TBG3 clone when
b-gal was exogenously provided. In contrast, they b-gal1 cells with a faster renewal rate. However, lack of
tolerance in Vim1 mice strongly suggests that cross-strongly stimulated the b-gal-specific class I±restricted
LacZ1.4 CTL clone (Figure 7F). Similar results were ob- priming is not the mechanism of tolerance induction of
CD4 T cells. This indicates that CD4 T cell tolerancetained with thymic mw (data not shown). These data
confirm that thymic DCs and mw can present nuclear induction requires b-gal to be presented by the MHC
class II endogenous presentation pathway of mTE cells.b-gal via the MHC class I but not the MHC class II
endogenous presentation pathway. The capacity of mTECs to use the MHC class II endoge-
nous pathway to present nuclear b-gal was confirmed
in vitro with mTECX.10 derived from Tg±b-gal thymusDiscussion
and with mTECs expressing nuclear b-gal after transfec-
tion or infection with adenovirus. The role of the MHCCD4 T cell tolerance induced by mTE has been studied
in three different experimental models, i.e., P→F1 BMC, class II endogenous presentation pathway in selecting
the CD4 T cell repertoire was highlighted by studies ofallogeneic embryonic thymus-grafted mice, and trans-
genic mice expressing foreign MHC molecules in thymic the antigen presentation by cortical TECs (Oukka et al.,
submitted). These cells have theunique ability to presentepithelium. However, these models do not allow a defini-
tive conclusion about the tolerogeneic capacity of mTE. endogenous but not exogenous b-gal, suggesting that
the most relevant peptides involved in positive selectionHere, we have studied the capacity of mTE to induce
tolerance of the CD4 T cell repertoire specific for an derive from endogenous proteins.
It is now well established that DC induce toleranceintracellular antigen. We used two lines of mice express-
ing the same antigen (b-gal) in the nucleus of mTE cells by clonal deletion after interaction of the TCR with MHC±
peptide ligands and delivery of a second signal (Page(Tg±b-gal mice) or in the nucleus of BM-derived thymic
DCs and mw (Vim1 mice). et al., 1993). Tolerance of b-gal-specific CD8 T cells of
Immunity
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Figure 7. MHC Class II Presentation of Nuclear b-Gal by mTECs
(A) TBG3 clone stimulated by mTEC2.3 in the presence of various
doses of exogenous b-gal.
(B) TBG3 clone stimulated by mTEC2.3 (closed bar), mTEC2.3BG
(hatched bar), and mTECX.10 (open bar) in the presence (100 mg/
ml) or absence of b-gal.
(C) TBG3 clone stimulated by mTEC2.3 infected with various doses
of AdCMVnLacZ (nuclearb-gal) (squares)or AdCMVcLacZ (cytosolic
b-gal) (circles).
(D) TBG3 clone stimulated by LB27.4 cells in the presence of 1/4
diluted supernatant of mTEC2.3 infected with 1,000 moi of Ad-Figure 6. Intracellular Distribution of b-Gal in mTECX.10 and in Re-
CMVnLacZ for 48 hr. b-gal was exogenously provided when indi-combinant Adenovirus-Infected mTEC2.3
cated.mTEC2.3 were infected with 1,000 moi of recombinant adenoviruses
(E) TBG3 clone stimulated by thymic DC from B6 (open bars) orfor 48 hr before X-gal assay. mTECX.10 were derived from Tg±b-
Vim1 (closed bars) mice. b-gal (10 mg/ml) was exogenously providedgal thymus.
when indicated.(A) mTEC2.3 infected with AdCMVnLacZ.
(F) LacZ1.4 cells stimulated by thymic DC from B6 (open bars) or(B) mTEC2.3 infected with AdCMVcLacZ.
Vim1 (closed bars) mice. b-gal497 peptide (20 mM) was exogenously(C) mTECX.10.
provided when indicated. Stimulation of LacZ1.4 clone was mea-
sured by tumor necrosis factor release assay.
Vim1 mice demonstrated that the subpopulation of
b-gal1 DCs in the thymus are competent to induce toler- nuclear proteins has never been reported (Weiss and
Bogen, 1989; Jaraquemada et al., 1990; Hackett et al.,ance. This also showed that absence or reduced expres-
sion of vimentin in Vim12/2 and Vim11/2 mice did not 1991; Malnati et al., 1992, 1993; Brooks and McCluskey,
1993). In agreement with these observations, we couldalter the capacity of DCs to induce tolerance. Therefore,
reactivity of b-gal-specific CD4 T cells in Vim1 mice is not obtain stimulation of the b-gal-specific TBG3 Th
clone by LB27.4 cells expressing very high amountslikely to reflect the inability of DCs and mw to use the
MHC class II endogenous pathway to present nuclear of nuclear b-gal in the nucleus. However, LB27.4 cells
presented cytosolic b-gal to the same Th clone (datab-gal in the thymus. This was confirmed in vitro with
purified thymic DCs and mw from Vim1 mice, which not shown). Therefore, it appears that presentation of
nuclear antigens via the MHC class II endogenous path-did not stimulate the TBG3 Th clone in the absence of
exogenous b-gal. Several reports have described class way can not be achieved by BM-derived cells.
Another possibility that might be considered to ex-II endogenous presentation of cytosolic proteins by pro-
fessional APCs like B cells but class II presentation of plain the anti-b-gal CD4 reactivity of Vim1 mice is that
Tolerance Induction by Medullary Thymic Epithelium
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to the cytosol, respectively, will be described elsewhere (P. L. T.,the processing of internalized and endogenous b-gal
unpublished data).generates different class II±restricted immunodominant
peptides. Therefore,DC may induce tolerance tonuclear
Cells
b-gal, but this would not be seen in vitro if the anti-b- EL4 (H-2b) T lymphoma cells and LB27.4 (H-2b/d) B lymphoma cells
gal response is directed against peptides derived from were cultured in our laboratory. mTEC2.3 (H-2b medullary thymic
internalized b-gal. We do not favor this possibility be- epithelial cell line) was obtained from Dr. Mizuochi (National Institute
of Health, Tokyo). EL4.T20 and mTEC2.3BG cells were establishedcause none of the reports describing class II presenta-
by transfection of EL4 and mTEC2.3 with the construct that hadtion by professional APCs showed that the presentation
been used for the generation of the Tg±b-gal mice. The b-gal1pathway influenced the panel of immunodominant pep-
mTECX.10 was derived from Tg±b-gal thymus and was described
tides of an antigen. previously (Oukka et al., 1996). TBG3 Th cell clone was established
Responsiveness of b-gal-specific Th cells from Tg±b- from b-gal-primed B6 LN cells and was maintained in culture by
gal mice was restored in vitro in the presence of exoge- stimulation with b-gal (10 mg/ml) and 2,000 rads irradiated B6 spleen
cells. b-gal-specific LacZ1.4 CTL clone was described previouslynous rIL-2, suggesting that anergy is a mechanism of
(Oukka et al., 1996).tolerance in these mice. Anergy can result from the defi-
ciency of nonprofessional APCs to deliver the second
Antigens
signal via costimulatory molecules like B7 (Harding et
b-gal was extracted from a culture of K12 Escherichia coli in the
al., 1992). Our results showing that b-gal1 TECs in Tg±b- laboratory of protein extraction (Centre National de la Recherche
gal thymus are B72 could explain the Th anergy in Tg±b- Scientifique, Gif-sur-Yvette, France). It was purified in a TPEG col-
umn as described (Ullman, 1984). b-gal497 peptide was synthetizedgal mice (Oukka et al., 1996). However, we can not
by Genosys Biotechnologies (Cambridge, United Kingdom)exclude the possibility that mTE induces tolerance by
deleting high avidity Th cells and that the remaining low
b-Gal Assayavidity Th cells require exogenous rIL-2 to respond to
b-gal expression was detected by histochemical staining procedure.
b-gal. TE-induced deletion of high avidity autoreactive In brief, thymi from 2-week-old mice were washed four times with
CD4 T cells has been suggested in several models of phosphate-buffered saline, fixed with 3% paraformaldehyde for 30
BMC (Gao et al., 1990; Burkly et al., 1993). Other obser- min, washed four times, and sequentially dipped in solution of 10%
sucrose for 20 min and 20% sucrose for 15 min. Frozen sections ofvations in BMC and embryonic thymus-grafted mice
treated thymi were incubated at 328C in a staining X-gal solution.suggested that TE induces a state of semitolerance that
disappears when thymocytes leave the thymus but be-
Immunohistochemical Staining
comes irreversible after a second contact of semitoler- Sections of paraffin-included thymi were treated with toluene plus
ized T cells with the antigen in the periphery (Webb ethanol, washed with 0.2% CaCl2, and incubated overnight at 328C
and Sprent, 1990; Gao et al., 1990; Sprent et al., 1993). in X-gal staining solution. After X-gal detection, sections were satu-
rated with 5% horse serum, incubated with primary antibodies (M5-However, in our experiments it appears that mTE-in-
114, Mac1, N418) for 1 hr at room temperature before incubationduced tolerance of CD4 T cells is a one-step process,
with horseradish peroxidase±conjugated secondary antibodies.since Tg±b-gal thymus-grafted nude mice expressing
Substrates to horseradish peroxidase were diaminobenzidine
b-gal exclusively in the grafted thymus were tolerant. (brown) or 3 amino-9 ethylcarbazole (red).
In normal thymus, the vast majority of proteins ex-
pressed by mTECs are likely to be coexpressed by Purification of Thymic DC
Thymi were treated with an enzyme cocktail (collagenase plusBM-derived cells. However, these cells have differential
DNAse) for 2 hr at 378C. Cells were centrifuged, resuspended inabilities to present MHC class II±associated peptides.
RPMI 1640 medium, and carefully overlayed on dense bovine serumAlthough BM-derived cells are very efficient at pre-
albumin. After 20 min of centrifugation at 8,000 rpm, the top bandsenting antigens, mTECs seemed to be the only cells in
was collected and cells were stained with DC-specific N418 MAb
the thymus to present peptides of nuclear origin via the before sorting on a FACStar Plus instrument (Becton Dickinson and
MHC class II endogenous presentation pathway. The Company, San Jose, California) (Crowley etal., 1989). Such a purified
cell population contained more than 95% DCs.data presented here suggest that mTE supplies the defi-
ciency of BM-derived cells to induce Th tolerance to
Thymus Graftingnuclear proteins. Thus, CD4 T cell tolerance is only com-
Thymus from neonate Tg±b-gal and NTg±b-gal mice were graftedpleted after negative selection of autoreactive T cells
subcutaneously to B6 nude mice. Immunofluorescence staining of
by BM-derived cells and mTE. thymocytes and LN cells with anti-CD4 and anti-CD8 MAbs indi-
cated that reconstitution of T cell populations in thymus and periph-
eral lymph nodes was completed 2 months after grafting (data not
Experimental Procedures shown).
Mice
Proliferative ResponseYoung adult male C57BL/6 (B6) and B6 nu/nu mice were obtained
Mice were immunized in the hind footpad with 50 mg of b-gal infrom Centre de DeÂ veloppement des Techniques AvanceÂ es pour
CFA. Popliteal LN were collected 9 days later and LN cells werel'expeÂrimentation animale of the Centre National de la Recherche
cultured at 5 3 105 cells/well with various concentrations ofScientifique in OrleÂ ans, France. The b2nZ 2 Tg (referred to as Tg±b-
b-gal in HL-1 medium (Ventrex Laboratories) supplemented withgal) mouse and Vim1 mice were described in detail previously (Co-
L-glutamine (2 mM) for 4 days. We added 1mCi per well of [3H]TdRhen-Tannoudji et al., 1992; Colucci-Guyon et al., 1994; Oukka et al.,
for the final 16 hr of the culture and radioactivity incorporation was1996).
counted in a b counter.
Stimulation of TBG3 Th Clone by mTECsViruses
Wild vaccinia virus (VV) and the recombinant vaccinia virus VVhrZ mTECs (2 3 104) were incubated in culture medium complemented
with 200 IU/ml of interferon-g for 48 hr. Adherent mTECs were(Wild et al., 1992) containing the lacZ gene were obtained from Dr.
R. Drillien. (Strasbourg, France). Recombinant adenoviruses Ad. washed twice and 2 3 104 TBG3 cells were added in a total volume
of 200 ml of culture medium (RPMI 1640 plus L-glutamine plus 2 3CMVnLacZ and Ad.CMVcLacZ targeting b-gal to the nucleus and
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1025 M 2ME plus 10% fetal calf cerum plus antibiotics). After 24 Burkly, L.C., Degermann, S., Longley, J., Hagman, J., Brinster, R.L.,
Lo, D., and Flavell, R.A. (1993). Clonal deletion of Vb51 T cells byhr, 50 ml of supernatant was added to 5 3 103 CTLL-2 cells and
proliferation was measured by the colorimetric method (Mosmann, transgenic I-E restricted to thymic medullary epithelium. J. Immunol.
151, 3954±3960.1983). For infection with recombinant adenoviruses, 2 3 104 mTECs
were incubated overnight with viruses before addition of Cohen-Tannoudji, M., Morello, D., and Babinet, C. (1992). Unex-
interferon-g. pected position dependent expression of H-2 and b2-m lacZ
transgenes. Mol. Rep. Dev. 33, 149±156.
Stimulation of TBG3 Th Clone by Thymic DC Colucci-Guyon, E., Portier, M.M., Dunia, I., Paulin, D., Pournin, D.,
TBG3 cells (2 3 104) were stimulated with 4 3 104 thymic DCs in and Babinet, C. (1994). Mice lacking vimentin develop and reproduce
complete culture medium (final volume 200 ml) in the absence or without an obvious phenotype. Cell 79, 679±694.
presence of 10 mg/ml of b-gal. After 24 hr, 50 ml of supernatant was
Crowley, M., Inaba, K., Witmer-Pack, M., and Steinman, R.M. (1989).added to 5 3 103 CTLL-2 cells and proliferation was measured by
The cell surface of mouse dendritic cells: FACS analyses of dendriticthe colorimetric method (Mosmann, 1983).
cells from different tissues including thymus. Cell. Immunol. 118,
108±125.
Generation of CTL
Gao, E.K., Lo, D., and Sprent, J. (1990). Strong T cell tolerance inFor b-gal-specific CTL, mice were immunized intravenously with 107
parent F1 bone marrow chimeras prepared with supralethal irradia-pfu of VVhrZ and 2 weeks later their spleen cells (5 3 106/well) were
tion. J. Exp. Med. 171, 1101±1121.stimulated with 5 3 105 10,000 rads irradiated EL4.T20 cells in a 24-
Hackett, C.J., Yewdell, J.W., Bennink, J.R., and Wysoka, M. (1991).well culture plate in 2 ml of complete culture medium for 5 days.
Class II restricted T cell determinants processed from either endo-For VV-specific CTL, spleen cells from B6 mice immunized with
somes or the cytosol show similar requirements for host proteinVVhrZ were cultured (5 3 106 cells/well) with 106 2,000 rads irradiated
transport but different kinetics of presentation. J. Immunol. 146,VV-infected B6 spleen cells (10 pfu/cell for 16 hr) in 2 ml of complete
2944±2951.culture medium for 5 days.
Harding, F.A., McArthur, B., Gross, J.A., Raulet, D.H., and Allison,
Cytotoxic Assay J.P. (1992). CD28 mediated signalling costimulated murine T cells
EL4 cells, VV-infected EL4 cells (10 pfu/cell for 16 hr), and EL4.T20 and prevents induction of anergy in T cell clones. Nature 356,
cells were used as targets for cytotoxicity. They were labeled with 607±609.
51Cr for 90 min and washed three times. Target cells (104) in 100 ml Hoffmann, M.W., Allison, J., and Miller, J.F.A.P. (1992). Tolerance
of RPMI 1640 plus 5% fetal calf serum were added to 100 ml of induction by thymic medullary epithelium. Proc. Natl. Acad. Sci.
various numbers of effector cells in 96-well round-bottomed plates USA 89, 2526±2530.
and were incubated for 4 hr at 378C. After incubation, 100 ml of
Hoffmann, M.W., Heath, W.R., Ruschmeyer, D., and Miller, J.F.A.P.supernatant was collected and the percentage of specific 51Cr re-
(1995). Deletion of high avidily T cells by thymic epithelium. Proc.lease was calculated as follows: percent release 5 experimental
Natl. Acad. Sci. USA 92, 9851±9855.release 2 spontaneous release / maximum release 2 spontaneous
Jameson, S.C., Hogquist, K.A., and Bevan, M.J. (1995). Positiverelease. Spontaneous release was 15%±20% of the maximal release
selection of thymocytes. Annu. Rev. Immunol. 13, 93±126.induced by HCl 3N.
Jaraquemada, D., Marti, M., and Long, E.O. (1990). An endogenous
processing pathway in vaccinia virus infected cells for presentationTumor Necrosis Factor Release Assay
of cytoplasmic antigens to class II restricted T cells. J. Exp. Med.LacZ1.4 CTL (2 3 103) was cocultured with 2 3 104 thymic DCs in
172, 947±954.100 ml in complete culture medium supplemented with 25 IU/ml of
rIL-2 in the presence or absence of 20 mM of b-gal497 peptide. After Jenkinson, E.J., Anderson, G., and Owen, J.J. (1992). Studies of T
24 hr, 50 ml of supernatant was harvested and transferred to a cell maturation on defined thymic stromal cell populations in vitro.
microplate containing 2 3 104 WEHI-164.13 cells in 50 ml of culture J. Exp. Med. 176, 845±853.
medium supplemented with 2 mg/ml of actinomycin D. After 20 hr
Kappler, J.W., Roehm, N., and Marrack, P. (1987). T cell tolerance
of incubation at 378C, proliferation was measured by colorimetric
by clonal elimination in the thymus. Cell 49, 273±280.method and the percentage of growth inhibition of WEHI-164.13
Kosaka, H., and Sprent, J. (1993). Tolerance of CD81 T cells devel-cells was determined as: (1 2 OD in sample wells / OD in wells with
oping in Parent→F1 chimeras prepared with supralethal irradiation:medium alone) 3 100% (Oukka et al., 1996).
step-wise induction of tolerance in the intrathymic and extrathymic
environments. J. Exp. Med. 177, 367±378.Acknowledgments
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